Natco Pharma seeks approval for Molnupiravir capsules for use in COVID-19 treatment

Hyderabad, Apr 26: Natco Pharma Limited on Monday said it applied to the Central Drugs Standard Control Organisation (CDSCO) for approval of Phase-III clinical trial of Molnupiravir Capsules for the treatment of COVID-19 positive patients.American pharma major Merck along withRidgeback Biotherapeuticshasdeveloped Molnupiravir(MK-4482).

from India News, India Breaking News, Latest news headlines in India - Oneindia News https://ift.tt/2QpH5mG

• Tweet
• Share
• Share
• Share
• Share

About Admin MC3

This is dummy text. It is not meant to be read. Accordingly, it is difficult to figure out when to end it. But then, this is dummy text. It is not meant to be read. Period.

Related Post